A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

@inproceedings{Lpez2010ARO,
  title={A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer},
  author={Rosa Torres L{\'o}pez and M Salgado and Margarita Reboredo and Carlos Grande and Jose Carlos M{\'e}ndez and M{\^o}nica De Paula Jorge and Carolina Ruiz Romero and Guillermo E. Quintero and Juan De La C{\'a}mara and Sonia Candamio},
  booktitle={British Journal of Cancer},
  year={2010}
}
Background:Combination of bevacizumab and FOLFIRI has currently become one of the standard therapeutic regimens. However, published information is still limited. The objective of the present retrospective observational study is to analyse the response and toxicity of first-line treatment with FOLFIRI+bevacizumab in patients with metastatic colorectal cancer (mCRC).Methods:Data were collected from patients from nine Spanish sites diagnosed with mCRC, ECOG⩽2, whose first treatment for advanced… CONTINUE READING